| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 20 |
| 1 | ADALIMUMAB | 17 |
| 2 | ETANERCEPT | 13 |
| 3 | LOSARTAN | 13 |
| 4 | PREGABALIN | 10 |
| 5 | ACETAMINOPHEN | 9 |
| 6 | HYDROCHLOROTHIAZIDE | 9 |
| 7 | OMEPRAZOLE MAGNESIUM | 9 |
| 8 | ALENDRONATE SODIUM | 8 |
| 9 | ERGOCALCIFEROL | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NARATRIPTAN | 3 | 0.0021 |
| 1 | ISRADIPINE | 1 | 0.0018 |
| 2 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 3 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 4 | STANNOUS FLUORIDE | 1 | 0.0014 |
| 5 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 6 | COAGULATION FACTOR IX (RECOMBINANT), FC FUSION PROTEIN | 3 | 0.0012 |
| 7 | ALMOTRIPTAN | 1 | 0.0009 |
| 8 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 9 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 2 | RANK Ligand Inhibitor [EPC] | 20 |
| 3 | Corticosteroid [EPC] | 14 |
| 4 | Kinase Inhibitor [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 10 |
| 6 | Proton Pump Inhibitor [EPC] | 10 |
| 7 | Thiazide Diuretic [EPC] | 10 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 2 | Oxytocic [EPC] | 1 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 6 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 7 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Vitamin K [EPC] | 1 | 0.0001 |